Research Topics
Species | C G GoetzSummaryAffiliation: Rush University Medical Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
The history of Parkinson's disease: early clinical descriptions and neurological therapiesChristopher G Goetz
Department of Neurological Sciences and Department of Pharmacology, Rush University Medical Center, Chicago, Illinois 60612, USA
Cold Spring Harb Perspect Med 1:a008862. 2011....
Motor function in Parkinson's disease and supranuclear palsy: simultaneous factor analysis of a clinical scale in several populationsPieter M Kroonenberg
Department of Education and Child Study, Wassenaarseweg 52, Leiden University, Leiden, The Netherlands
BMC Med Res Methodol 6:26. 2006....
Temporal stability of the Unified Dyskinesia Rating ScaleChristopher G Goetz
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
Mov Disord 26:2556-9. 2011..The UDysRS has strong internal consistency and a reliable factor structure, but the important issue of temporal stability has not been established...
Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trialChristopher G Goetz
Rush University Medical Center, Chicago, Illinois 60612, USA
Mov Disord 22:179-86. 2007..Sarizotan 2 mg/day is a safe agent in PD patients with dyskinesia. To test its role in abating dyskinesia, future studies should focus on this dose and will use the composite score of UPDRS Items 32+33 as the primary outcome...
Early cinematographic studies of generalized dystoniaChristopher G Goetz
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
Mov Disord 21:1561-5. 2006..The films demonstrate the variety of dystonic movements appreciated during this period, consider psychogenic, postencephalitic, and hereditary forms, and refer to the treatment of dystonia by surgery and plaster casts...
Safety of rasagiline in elderly patients with Parkinson diseaseC G Goetz
Rush University Medical Center, Chicago, IL 60612, USA
Neurology 66:1427-9. 2006..This absence of an age-rasagiline interaction suggests that rasagiline does not require special safety precautions for elderly subjects with Parkinson disease...
The malignant course of "benign hallucinations" in Parkinson diseaseChristopher G Goetz
Department of Neurological Sciences, Rush University Medical Center, 1725 W Harrison Street, Chicago, IL 60612, USA
Arch Neurol 63:713-6. 2006..To monitor progression of "benign hallucinations" in Parkinson disease (PD)...
Does seasonal variation affect hallucinations in PD? A longitudinal studyChristopher G Goetz
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
Mov Disord 21:863-5. 2006..Because we found no evidence of seasonal variations, we cannot recommend phototherapy or other strategies affecting chronobiological systems as research priorities to treat PD hallucinations. (c) 2006 Movement Disorder Society...
Charcot in contemporary literatureChristopher G Goetz
Neurological Sciences and Pharmacology, Rush University Medical Center, IL 60612, USA
J Hist Neurosci 15:22-30. 2006..Neurologists should not look to these works as replacements for more seriously composed historical studies, but as enrichments anchored in the imaginative possibilities of Charcot and his fin de siècle era...
Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patientsChristopher G Goetz
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
Mov Disord 21:267-70. 2006..Age-related disinhibition may facilitate wider cortical activation in PD and potentiate aberrant signaling that invokes other types of hallucinations besides the classic visual forms...
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004Christopher G Goetz
Department of Neurological Sciences, Department of Pharmacology, Rush University Medical Center, Chicago, Illinois 60612, USA
Mov Disord 20:523-39. 2005..We consider a 3-year period a reasonable time frame for published updates and are working to establish a Web-based mechanism to update the report in an ongoing manner...
Hallucinations and sleep disorders in PD: six-year prospective longitudinal studyChristopher G Goetz
Department of Neurological Sciences, Rush Medical College, Rush University, Chicago, IL, USA
Neurology 64:81-6. 2005..To prospectively assess the relationship of hallucinations to sleep disorders in patients with Parkinson disease (PD) over 6 years...
Movement disorders: understanding clinical trialsChristopher G Goetz
Rush University Medical Center, Chicago IL 60612, USA
Lancet Neurol 4:5-6. 2005
Assuring interrater reliability for the UPDRS motor section: utility of the UPDRS teaching tapeChristopher G Goetz
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
Mov Disord 19:1453-6. 2004..Raters have the greatest difficulty with the mildest impairment, making training especially important to studies of early PD...
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendationsChristopher G Goetz
Rush University Medical Center, 1725 W Harrison Street, Chicago, IL 60612, USA
Mov Disord 19:1020-8. 2004..5 increments, this adaptation warrants clinimetric testing. Without such testing, however, the original five-point scales should be maintained...
Medical-legal issues in Charcot's neurologic careerChristopher G Goetz
Rush University Medical Center, Chicago, IL 60612, USA
Neurology 62:1827-33. 2004..Trace the medical-legal involvement of the 19th century clinical neurologist Jean-Martin Charcot...
Standardized training tools for the UPDRS activities of daily living scale: newly available teaching programChristopher G Goetz
Department of Neurological Sciences, Rush University, Rush Presbyterian St Luke s Medical Center, Chicago, Illinois, USA
Mov Disord 18:1455-8. 2003..The written materials and videotape belong to the Movement Disorder Society and are available by contacting the MDS central office...
Impact of placebo assignment in clinical trials of Parkinson's diseaseChristopher G Goetz
Department of Neurological Sciences, Rush University Rush Presbyterian St Luke s Medical Center, Chicago, Illinois 60612, USA
Mov Disord 18:1146-9. 2003..Although most wish they received the active compound being tested, the overall view of participation in placebo-controlled trials is viewed very positively by PD patients...
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing planChristopher G Goetz
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
Mov Disord 22:41-7. 2007....
J.-M. Charcot and simulated neurologic disease: attitudes and diagnostic strategiesChristopher G Goetz
Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA
Neurology 69:103-9. 2007..Neurologists have long wrestled with the diagnosis of elaborated or feigned disease. Studies have not focused on early techniques utilized to diagnose malingering...
Visual plus nonvisual hallucinations in Parkinson's disease: development and evolution over 10 yearsChristopher G Goetz
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
Mov Disord 26:2196-200. 2011..To capture the breadth and severity of hallucinations in chronically hallucinating patients with Parkinson's disease, screening inventories and practice-based interviews must include questions on both visual and nonvisual components...
The movement disorder society and movement disorders: a modern historyChristopher G Goetz
Rush University Medical Center, Chicago, Illinois 60612, USA
Mov Disord 26:939-46. 2011..Movement Disorders has a continuingly growing subscribership and rising impact factor...
Hallucinations and sleep disorders in PD: ten-year prospective longitudinal studyChristopher G Goetz
Movement Disorders Section, Department of Neurological Sciences, Rush University Medical Center, Suite 1106, Chicago, IL 60612, USA
Neurology 75:1773-9. 2010..To assess prospectively progression and relationship of hallucinations and sleep disorders over a 10-year longitudinal study of patients with Parkinson disease (PD)...
Teaching program for the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS-UPDRS)Christopher G Goetz
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
Mov Disord 25:1190-4. 2010..This training program is in English, but as non-English official translations of the MDS-UPDRS are developed, the program can be potentially modified into different languages...
Shaking up the Salpetriere: Jean-Martin Charcot and mercury-induced tremorChristopher G Goetz
Rush University Medical Center, Chicago, IL 60612, USA
Neurology 74:1739-42. 2010..To analyze Jean-Martin Charcot's studies of mercury-induced tremor...
New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's diseaseChristopher G Goetz
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
Mov Disord 25:S104-9. 2010..New treatments are being developed, but there have been very few large-scale randomized clinical trials to test the relative roles of new or available agents for abating these problematic behaviors...
Scales to evaluate psychosis in Parkinson's diseaseChristopher G Goetz
Rush University Medical Center, Chicago, IL 60612, USA
Parkinsonism Relat Disord 15:S38-41. 2009..The Task Force officially recommended the development of a new scale to assess hallucinations and psychosis in Parkinson's disease. This effort is now ongoing with official endorsement by the Movement Disorder Society...
Chapter 15: Jean-Martin Charcot and the anatomo-clinical method of neurologyChristopher G Goetz
Department of Neurological Sciences and Pharmacology, Rush University Medical Center, Chicago, IL 60612, USA
Handb Clin Neurol 95:203-12. 2010..In the context of Charcot's extensive discoveries and lasting contributions, the anatomo-clinical method remains the anchor of modern neurological diagnosis and is Charcot's most important contribution to clinical neurology...
Jean-Martin Charcot and his vibratory chair for Parkinson diseaseChristopher G Goetz
Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
Neurology 73:475-8. 2009..Although after Charcot's death vibratory therapy was not widely pursued, vibratory appliances are reemerging in 21st century medicine and can be retested using adaptations of Charcot's neurologic protocols...
Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at-home testing deviceChristopher G Goetz
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
Mov Disord 24:551-6. 2009....
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing resultsChristopher G Goetz
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
Mov Disord 23:2129-70. 2008..90 for each part), which support the use of sum scores for each part in preference to a total score of all parts. The combined clinimetric results of this study support the validity of the MDS-UPDRS for rating PD...
The Unified Dyskinesia Rating Scale: presentation and clinimetric profileChristopher G Goetz
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
Mov Disord 23:2398-403. 2008..The UDysRS is a clinimetrically sound rating scale for dyskinesia in PD, demonstrating acceptable levels of internal consistency and inter- and intra-rater reliability. Testing scale responsivity to treatment interventions is planned...
Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: Positive impact on long-term worseningChristopher G Goetz
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
Mov Disord 23:1541-5. 2008....
Evaluating Parkinson's disease patients at home: utility of self-videotaping for objective motor, dyskinesia, and ON-OFF assessmentsChristopher G Goetz
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
Mov Disord 23:1479-82. 2008..In this group of patients with no or mild fluctuations, in spite of pretrial training, patients were inaccurate in separating ON vs. OFF status...
Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventionsChristopher G Goetz
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
Mov Disord 23:690-9. 2008..Recognition of factors that impact placebo response rates should be incorporated into individual study designs for PD clinical trials...
Placebo influences on dyskinesia in Parkinson's diseaseChristopher G Goetz
Rush University Medical Center, Chicago, Illinois, USA
Mov Disord 23:700-7. 2008..The magnitude and variance of placebo-related changes and the factors that influence them can be helpful in the design of future clinical trials of antidyskinetic agents...
Pierre Marie: gifted intellect, poor timing and unchecked emotionalityChristopher G Goetz
Department of Neurological Sciences, Rush University Rush Presbyterian St Luke s Medical Centre, 1725 W Harrison Street, Suite 755, Chicago, IL 60612, USA
J Hist Neurosci 12:154-66. 2003..In the context of his time, these elements prompted Marie to enter into controversies and medico-political battles that advanced neurological knowledge, but likely disadvantaged him in his career successes...
Battle of the titans: Charcot and Brown-Séquard on cerebral localizationC G Goetz
Rush University Rush Presbyterian St Luke s Medical Center, Chicago, IL 60612, USA
Neurology 54:1840-7. 2000....
Progression of gait, speech and swallowing deficits in progressive supranuclear palsyChristopher G Goetz
Department of Neurological Sciences, Rush University Rush Presbyterian St Luke s Medical Center, Chicago, IL, USA
Neurology 60:917-22. 2003..To identify outcome measures for clinical trials in progressive supranuclear palsy (PSP), the authors determined the time to key motor impairments in a well-defined patient cohort...
Jean-Martin Charcot and the aging brainChristopher G Goetz
Department of Neurological Sciences and Pharmacology, Rush University/Rush-Presbyterian-St Luke's Medical Center, 1725 W Harrison St, Chicago, IL 60612, USA
Arch Neurol 59:1821-4. 2002
Teaching program for the Unified Dyskinesia Rating ScaleChristopher G Goetz
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
Mov Disord 24:1296-8. 2009..Large-scale multicenter randomized clinical trials of dyskinesia treatment are strengthened by a uniform standard of scale application...
The prefaces by Charcot: leitmotifs of an international careerChristopher G Goetz
Department of Neurological Sciences, Rush University Rush Presbyterian St Luke s Medical Center, Chicago, IL 60612, USA
Neurology 60:1333-40. 2003....
Amyotrophic lateral sclerosis: early contributions of Jean-Martin CharcotC G Goetz
Department of Neurological Sciences, Rush University Rush Presbyterian St Luke s Medical Center, Chicago, Illinois 60612, USA
Muscle Nerve 23:336-43. 2000..Because of Charcot's fundamental contributions, the eponym "Charcot's disease" has been used internationally in association with amyotrophic lateral sclerosis...
The Brown-Séquard and S. Weir Mitchell lettersC G Goetz
Rush Medical College Rush Presbyterian St Luke s Medical Center, Chicago, IL, USA
Neurology 57:2100-4. 2001....
Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's diseaseChristopher G Goetz
Department of Neurological Sciences Rush University, Rush Presbyterian St Luke s Medical Center, Chicago, Illinois 60612, USA
Mov Disord 17:283-8. 2002....
Poor Beard!! Charcot's internationalization of neurasthenia, the "American disease"C G Goetz
Rush University Rush Presbyterian St Luke s Medical Center, Chicago, IL, USA
Neurology 57:510-4. 2001..To analyze the role of the seminal 19th-century neurologist, Jean-Martin Charcot, in the internationalization of neurasthenia, previously known as "the American disease."..
[Progressive supranuclear palsy]C G Goetz
Rush University, Presbyterian St Luke s Medical Center, 1725, West Harrison street, Suite 755, Chicago, IL 60612, USA
Rev Neurol (Paris) 159:3S25-9. 2003..The Kaplan-Meier curves show that the mean duration of the disease before development of one of these signs is 50 months. Research on protocols designed to stop disease progression should be centered on this period...
Acute orthostatic hypotension when starting dopamine agonists in Parkinson's diseaseK Kujawa
Department of Neurological Sciences, Rush Presbyterian St Luke s Medical Center, Chicago, IL, USA
Arch Neurol 57:1461-3. 2000..To study the frequency and severity of acute orthostatic hypotension (OH) in patients with Parkinson's disease who are starting dopamine agonist therapy...
Prospective longitudinal assessment of hallucinations in Parkinson's diseaseC G Goetz
Department of Neurological Sciences, Rush University, Chicago, IL, USA
Neurology 57:2078-82. 2001..The consistent association of hallucinations with combined levodopa/agonist therapy suggests that these drugs may play a role in the pathophysiology of hallucinations...
Early morning off-medication dyskinesias, dystonia, and choreic subtypesE Cubo
Department of Neurological Sciences, Rush Presbyterian St Luke s Medical Center, Chicago, IL, USA
Arch Neurol 58:1379-82. 2001..Early morning off-medication choreic dyskinesias have been recently reported after fetal dopaminergic cell transplantations in patients with advanced PD...
Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's diseaseK Kompoliti
Department of Neurological Sciences, Rush Presbyterian St Luke s Medical Center, Rush University, Chicago, IL, USA
Neurology 54:458-62. 2000..To determine the effect of central dopaminergic stimulation with apomorphine on speech in PD...
Delayed recognition memory in Parkinson's disease: a role for working memory?G T Stebbins
Department of Neurological Sciences, Rush Medical College, Chicago, IL 60612, USA
Neuropsychologia 37:503-10. 1999..These results suggest that the same cognitive processes which support performance on tests of recall and working memory also support performance on tests of delayed recognition...
Impaired frontostriatal cognitive functioning following posteroventral pallidotomy in advanced Parkinson's diseaseG T Stebbins
Department of Neurological Sciences, Rush Medical College, Chicago, IL 60612, USA
Brain Cogn 42:348-63. 2000..These results suggest that the posteroventral pallidotomy selectively impairs performance on tests of frontostriatal cognitive abilities...
Movement disorders in KuruK Kompoliti
Rush Presbyterian St Luke s Medical Center, Rush University, Chicago, Illinois, USA
Mov Disord 14:800-4. 1999..To describe the gamut of movement disorders (MD) seen during the clinical course of kuru...
Objective changes in motor function during placebo treatment in PDC G Goetz
Department of Neurological Sciences, Rush University, Rush Presbyterian St Luke s Medical Center, Chicago, IL 60612, USA
Neurology 54:710-4. 2000..To examine the frequency, temporal development, and stability of objectively derived motor changes during placebo treatment in PD and to define the clinical domains and demographic groups most affected...
Altered cortical visual processing in PD with hallucinations: an fMRI studyG T Stebbins
Department of Neurological Sciences, Rush University Medical Center, 1725 West Harrison Street, Suite 309, Chicago, IL 60612, USA
Neurology 63:1409-16. 2004..To compare fMRI activation during two visual stimulation paradigms in Parkinson disease (PD) subjects with chronic visual hallucinations vs PD patients who had never hallucinated...
Menstrual-related changes in motoric function in women with Parkinson's diseaseK Kompoliti
Department of Neurological Sciences, Rush Presbyterian St Luke s Medical Center, Rush University, Chicago, IL, USA
Neurology 55:1572-5. 2000..Although PD severity fluctuated during the study period, there was no significant correlation between the objective or subjective measures of parkinsonism and estrogen and progesterone levels...
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamicsK Kompoliti
Department of Neurological Science, Rush Presbyterian St Luke s Medical Center, Chicago, IL 60612, USA
Neurology 58:1418-22. 2002..5 mg/d and 4.5 mg/d of PPX or placebo. Compared to men, women had greater LD bioavailability. PPX did not alter LD bioavailability, and PPX pharmacokinetics were equivalent in men and women...
Home alone: methods to maximize tic expression for objective videotape assessments in Gilles de la Tourette syndromeC G Goetz
Department of Neurological Sciences, Rush University, Rush Presbyterian St. Luke's Medical Center, Chicago, Illinois, USA
Mov Disord 16:693-7. 2001..Because at-home videotapes consistently yield higher tic expressions than in-office films and capture tics that are not appreciated by patients, this methodology is well-suited for enhanced retrieval of objective data on tic expression...
Clinical presentation and pharmacological therapy in corticobasal degenerationK Kompoliti
Rush Presbyterian St Luke s Medical Center, Chicago, Ill 60612, USA
Arch Neurol 55:957-61. 1998..To date, to our knowledge, there is no systematic presentation of treatment outcome in large series of patients clinically diagnosed as having corticobasal degeneration...
The election of Sarah McNutt as the first woman member of the American Neurological AssociationStacy S Horn
Department of Neurological Sciences, Rush University, Chicago, IL 60612, USA
Neurology 59:113-7. 2002..Her historic election acknowledged her accomplishments and highlighted the proactive role of the early ANA in forging new medical policies in the United States...
Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodiesJennifer G Goldman
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
Mov Disord 23:2248-50. 2008..Our results suggest that dopaminergic medications have limited benefit in DLB because of the low likelihood of motor improvement and the risk of psychosis exacerbation...
Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivationElizabeth Berry-Kravis
Department of Pediatrics, Rush University Medical Center, 1275 West Harrison Street, Suite 718, Chicago, IL 60612, USA
Ann Neurol 57:144-7. 2005....
History of the extensor plantar response: Babinski and Chaddock signsChristopher G Goetz
Rush Medical College, Chicago, Illinois, USA
Semin Neurol 22:391-8. 2002....
Tremor and ataxia in fragile X premutation carriers: blinded videotape studyElizabeth Berry-Kravis
Department of Neurological Sciences, Rush Presbyterian St Luke s Medical Center, Chicago, IL 60612, USA
Ann Neurol 53:616-23. 2003..Given the relatively high population frequency of the FMR1 premutation, this mutation may be a significant cause of late-onset "idiopathic" progressive tremor...
Association between antipsychotics and body mass index when treating patients with ticsKatie Kompoliti
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illionois 60612, USA
J Child Adolesc Psychopharmacol 20:277-81. 2010..The objective of this study is to investigate the relationship between antipsychotic use and weight in tic patients and compare the effects of SGAs to first-generation (typical) antipsychotics (FGAs)...
Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin systemJennifer G Goldman
Department of Neurological Sciences, Rush Presbyterian St Luke s Medical Center, Chicago, Ill 60612, USA
Arch Neurol 61:1280-4. 2004..Because CCK gene polymorphisms vary across ethnic groups, the presence of similar associations in white PD subjects merits investigation...
Charcot and Pasteur: intersecting orbits in fin de siècle French medicineChristopher G Goetz
Rush University Medical Center, Chicago, IL 60612, USA
J Hist Neurosci 18:378-86. 2009..With different primary interests and different etiological views, side by side, they exemplified two models of French medicine at the close of the nineteenth century: medical scientist and scientific physician...
Neuropathic features in fragile X premutation carriersElizabeth Berry-Kravis
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
Am J Med Genet A 143:19-26. 2007..These data suggest that neuropathic signs are associated with the fragile X premutation, presumably occurring through the same mechanism proposed for CNS disease, namely, toxicity from expanded-CGG-repeat FMR1 mRNA...
Determinants of quality of life in children with Gilles de la Tourette syndromeBryan A Bernard
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
Mov Disord 24:1070-3. 2009..ADHD with predominantly inattentive symptoms, rather than hyperactivity symptoms, was associated with lower QOL. To improve QOL, clinicians must consider treatments of co-morbidities among tic patients...
Gilles de la Tourette syndrome: patient's knowledge and concern of adverse effectsKatie Kompoliti
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
Mov Disord 21:248-52. 2006..Overall, patient awareness of NL side effects is insufficient, and although past exposure to NLs enhances knowledge, it decreases concern...
Ballistic-choreic movements as the presenting feature of renal cancerK A Kujawa
Department of Neurology Sciences, Rush Presbyterian St Luke s Medical Center, Chicago, IL, USA
Arch Neurol 58:1133-5. 2001..To our knowledge, severe, rapidly progressive, and drug-resistant ballistic-choreic movements have not been previously described as the presenting feature of renal cell carcinoma...
Charcot and the myth of misogynyC G Goetz
Rush University Rush Presbyterian St Luke s Medical Center, Chicago, IL 60612, USA
Neurology 52:1678-86. 1999..To evaluate Jean-Martin Charcot's attitudes toward women and evaluate contemporary and modern accusations of misogyny...
Pharmacological therapy in progressive supranuclear palsyK Kompoliti
Rush Presbyterian St Luke s Medical Center, Chicago, Ill 60612, USA
Arch Neurol 55:1099-102. 1998..To our knowledge, previous reports on drug treatment in progressive supranuclear palsy have not evaluated autopsy-confirmed cases...
Estrogen supplementation in the posthypoxic myoclonus rat modelK Kompoliti
Department of Neurological Sciences, Rush University, Chicago, Illinois 60612, USA
Clin Neuropharmacol 24:58-61. 2001..Estrogen enhances and prolongs posthypoxic myoclonus, suggesting that female gender and estrogen status may play a pivotal role as a risk factor for human posthypoxic myoclonus...
Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosisChristopher G Goetz
Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
Ann Neurol 64:S81-92. 2008..The inclusion criteria can be applied internationally and in multicenter research on treatment interventions, clinicopathological correlations, and studies of cognitive and other nonmotor elements of PD...
Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control studyC G Goetz
Department of Neurological Sciences, Rush University Rush Presbyterian St Luke s Medical Center, 1725 W Harrison St, Chicago, IL 60612, USA
Arch Neurol 58:209-13. 2001..Another study linked the apolipoprotein E4 (APOE4) allele to hallucinations in PD...
Treatment of advanced Parkinson's disease: an evidence-based analysisChristopher G Goetz
Department of Neurological Sciences, Department of Pharmacology, Rush University/Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, USA
Adv Neurol 91:213-28. 2003
Comparison of tic characteristics between children and adultsEsther Cubo
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
Mov Disord 23:2407-11. 2008..004) when compared with adults. Tic phenomenology and severity were similar between children and adults, but pharmacological tic management was different, perhaps reflecting a practice trend to avoid medications in children...
Treatment of tremor and dystoniaC G Goetz
Department of Neurological Sciences, Rush University-Rush Presbyterian-St. Luke's Medical Center, Chicago, Illinois, USA
Neurol Clin 19:129-44, vi-vii. 2001..A discussion of idiopathic and secondary dystonia with focus on diagnosis and medical and surgical treatments encompasses the second part of the article...
Movement disorders caused by medical diseaseBrandon Barton
Department of Neurological Sciences, Movement Disorders Section, Rush University Medical Center, Chicago, Illinois 60612, USA
Semin Neurol 29:97-110. 2009..The spectrum of medical diseases associated with these four syndromes is reviewed in this article...
Part 1: the history of 19th century neurology and the American Neurological AssociationChristopher G Goetz
Ann Neurol 53:S2-S26. 2003
Mitochondrial polymorphisms significantly reduce the risk of Parkinson diseaseJoelle M van der Walt
Department of Medicine, and Center for Human Genetics, Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, NC 27710, USA
Am J Hum Genet 72:804-11. 2003..45; 95% CI 0.22-0.93; P=.03). Our results suggest that ND3 is an important factor in PD susceptibility among white individuals and could help explain the role of complex I in PD expression...
A responsive outcome for Parkinson's disease neuroprotection futility studiesJordan J Elm
Department of Biostatistics, Bioinformatics and Epidemiology, Medical University of South Carolina, Charleston, SC 29425, USA
Ann Neurol 57:197-203. 2005....
Coping strategies for visual hallucinations in Parkinson's diseaseNico J Diederich
Department of Neuroscience, Centre Hospitalier de Luxembourg, Luxembourg
Mov Disord 18:831-2. 2003..We found that 36 of our 46 Parkinson's disease subjects with hallucinations (78%) used coping strategies: cognitive techniques in 69%; interactive techniques in 62%; and visual techniques in 33%...
Parkinson disease with old-age onset: a comparative study with subjects with middle-age onsetNico J Diederich
Department of Neuroscience, Centre Hospitalier de Luxembourg, Luxembourg
Arch Neurol 60:529-33. 2003..To our knowledge, no prior study has focused on subjects with Parkinson disease (PD) with elderly disease onset, and there is little evidence-based knowledge of treatment outcomes in these patients...
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's diseaseC Warren Olanow
Department of Neurology, Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029, USA
Ann Neurol 54:403-14. 2003..Fetal nigral transplantation currently cannot be recommended as a therapy for PD based on these results...
Parkin mutations and susceptibility alleles in late-onset Parkinson's diseaseSofia A Oliveira
Department of Medicine and Center for Human Genetics, Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, NC 27710, USA
Ann Neurol 53:624-9. 2003..These findings suggest that mutations in Parkin contribute to the common form of PD and that heterozygous mutations, especially those lying in exon 7, act as susceptibility alleles for late-onset form of Parkinson disease...
Short-term and practice effects of metronome pacing in Parkinson's disease patients with gait freezing while in the 'on' state: randomized single blind evaluationEsther Cubo
Department of Neurology, Sanatorio del Rosario, Clinica de la Zarzuela, Principe de Vergara 53 28006, Madrid, Spain
Parkinsonism Relat Disord 10:507-10. 2004..In a randomized single blind parallel study, we tested the efficacy of an auditory metronome on walking speed and freezing in Parkinson's disease (PD) patients with freezing gait impairment during their 'on' function...
Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study)C Warren Olanow
Department of Neurology, Mount Sinai School of Medicine, New York, New York, USA
Clin Neuropharmacol 27:58-62. 2004
Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disordersIrene Litvan
Movement Disorder Program, University of Louisville, KY 40205, USA
Mov Disord 18:467-86. 2003..In each of these areas, diagnosis continues to rest on clinical findings and the judicious use of ancillary studies...
Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative modelNico J Diederich
Department of Neuroscience, Centre Hospitalier de Luxembourg, Luxembourg
Mov Disord 20:130-40. 2005..This new conceptual framework permits an anatomical view of VH and suggests new, testable hypotheses regarding their pathophysiology and therapy...
The origins of scientific cinematography and early medical applicationsAlexandru C Barboi
Medical College of Wisconsin, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 53226, USA
Neurology 62:2082-6. 2004..To examine the neurologic cinematographic contributions of Gheorghe Marinescu...
Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementiaBarbara Jasinska-Myga
Department of Neurology, Ageing, Degenerative and Cerebrovascular Diseases, Medical University of Silesia, Central University Hospital, Medykow 14, Katowice 40 752, Poland
Arch Neurol 64:261-5. 2007..There have been conflicting reports of association of APOE polymorphism with dementia in Parkinson disease (PD)...
Scales to assess psychosis in Parkinson's disease: Critique and recommendationsHubert H Fernandez
Department of Neurology, McKnight Brain Institute University of Florida, Gainesville, Florida 32611, USA
Mov Disord 23:484-500. 2008..The CGIS is suggested as a secondary outcome scale to measure change and response to treatment over time...
Depression rating scales in Parkinson's disease: critique and recommendationsAnette Schrag
University Department of Clinical Neurosciences, Royal Free and University College Medical School, London, UK
Mov Disord 22:1077-92. 2007..The complex and time-consuming task of developing a new scale to measure depression specifically for patients with PD is currently not warranted...
Levodopa-induced dyskinesiasGiovanni Fabbrini
Department of Neurological Sciences University of Rome La Sapienza, Rome, Italy
Mov Disord 22:1379-89; quiz 1523. 2007..New rating measures to assess severity and disability related to dyskinesia are in the process of development and clinimetric testing...
Contribution of Jules Froment to the study of parkinsonian rigidityEmmanuel Broussolle
Universite de Lyon, Universite Claude Bernard Lyon I, Faculté de médecine Lyon Sud, Lyon, France
Mov Disord 22:909-14. 2007..In their number, breadth, and originality, Froment's contributions to the study of parkinsonian rigidity remain currently relevant to clinical and neurophysiological issues of PD...
Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trialsPaulo Guimaraes
Dept of Biostatistics, Bioinformatics and Epidemiology, Medical University of South Carolina, 135 Cannon St Suite 303, Charleston, SC 29425, USA
Clin Trials 2:509-18. 2005..Models can help better understand behavior of the UPDRS after initiation of symptomatic therapy when scores will improve and eventually start deteriorating again...
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's diseaseJoseph H Friedman
Parkinson Disease and Movement Disorders Center, NeuroHealth, Warwick, Rhode Island 02886, USA
Mov Disord 21:2078-81. 2006..While some patients had a favorable response, aripiprazole was associated with an exacerbation of motor symptoms. In this small study on psychosis in PD, aripiprazole did not appear promising...
The placebo treatments in neurosciences: New insights from clinical and neuroimaging studiesNico J Diederich
Department of Neurosciences, Centre Hospitalier de Luxembourg, 4, Rue Barble, L 1210 Luxembourg City, Luxembourg
Neurology 71:677-84. 2008..In depression, PL partially imitates selective serotonin reuptake inhibitor-mediated brain activation. Diseases lacking major "top-down" or cortically based regulation may be less prone to PL-related improvement...
Research Grants
- Multiple Factors Affecting Placebo Response in PDChristopher Goetz; Fiscal Year: 2004..Defining these determinant influences will help enhance placebo responses in clinical practice and control them in clinical trials. ..
